Dare Bioscience Inc (DARE) — Capital Reinvestment Ratio
Latest as of December 2025:
0.14x
Dare Bioscience Inc (DARE) has a Capital Reinvestment Ratio of 0.14x as of December 2025, meaning it reinvests 0% of its operating cash flow ($1.44 Million) in capital expenditures ($206.64K). See Dare Bioscience Inc (DARE) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.14x
Capex / Operating Cash Flow
Operating Cash Flow
$1.44 Million
USD
Capital Expenditures
$206.64K
USD
Data as of
Dec 2025
Most recent filing
Dare Bioscience Inc Capital Reinvestment Ratio (2024–2024)
This chart tracks Dare Bioscience Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Dare Bioscience Inc (2024–2024)
Year-by-year Capital Reinvestment Ratio for Dare Bioscience Inc from 2024 to 2024. For live market cap and broader valuation context, see Dare Bioscience Inc (DARE) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | $5.39 Million | $573.05K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow